Anh-Quan Nguyen, MD
Interventional Cardiology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nguyen’s office at (800) 597-2234 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A102865 · Current
Licensed to practise in California · since 2008 · expires 2027-10-31 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$368,609
Medicare paid this office $368,609 for 1,567 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 525 | $91,434 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 228 | $51,302 | $194 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 77 | $35,978 | $461 |
| Ultrasound of both sides of head and neck blood flow | 99 | $18,769 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $14,133 | $105 |
See all 36 services
| Return visit (30+ min) | 525 | $91,434 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 228 | $51,302 | $194 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 77 | $35,978 | $461 |
| Ultrasound of both sides of head and neck blood flow | 99 | $18,769 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $14,133 | $105 |
| Long return visit (40+ min) | 69 | $13,144 | $164 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 22 | $10,898 | $57 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 46 | $10,165 | $221 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $9,882 | $154 |
| Short return visit (20+ min) | 109 | $9,082 | $75 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 14 | $7,068 | $71 |
| New patient visit (45+ min) | 46 | $6,312 | $137 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 100 | $6,185 | $60 |
| Anticoagulant management of patient taking warfarin | 244 | $5,812 | $10 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 19 | $5,403 | $284 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 76 | $4,910 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 78 | $4,572 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 301 | $4,308 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 66 | $4,082 | $61 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 25 | $3,229 | $129 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $2,949 | $184 |
| Ultrasound study of arm and leg arteries | 33 | $2,792 | $82 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 64 | $2,691 | $42 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 99 | $2,371 | $22 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 13 | $2,305 | $177 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 77 | $1,538 | $10 |
| Heart rhythm recording of continous external ekg over 8-15 days | 97 | $1,362 | $13 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $1,342 | $79 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 47 | $1,205 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 161 | $1,195 | $7 |
| New patient visit (30+ min) | 11 | $1,186 | $108 |
| Injection, regadenoson, 0.1 mg | 48 | $1,080 | None |
| Programming of dual lead pacemaker system | 41 | $1,047 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 37 | $983 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $411 | $11 |
| Ultrasonic guidance for blood vessel access | 18 | $216 | $12 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 17 | More than 43% of doctors who do this |
Who their Medicare patients are
1,567 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 24% · Women 49% · Also on Medicaid 11% · Health risk score 1.41. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 42% · Atrial fibrillation 40% · Diabetes 31% · Chronic kidney disease 29% · Heart failure 24% · Cancer 16% · Depression 16% · COPD 13% · Stroke 12% · Dementia 11%.
The office billed $1,727,386, Medicare allowed $493,281 and paid $368,609; for 4,874 services of 79 kinds; $1,156 of it was for drugs given in the office and $367,452 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,567 | 4,874 | 78 | 1.41 | $1,727,386 | $368,609 |
| 2023 | 1,274 | 4,270 | 78 | 1.49 | $1,516,065 | $357,420 |
| 2022 | 1,388 | 5,054 | 78 | 1.37 | $1,882,133 | $492,600 |
| 2021 | 1,366 | 5,564 | 78 | 1.43 | $2,111,059 | $570,263 |
| 2020 | 1,094 | 5,087 | 78 | 1.49 | $1,925,049 | $499,122 |
| 2019 | 1,078 | 5,091 | 78 | 1.51 | $1,988,083 | $504,740 |
| 2018 | 1,042 | 5,256 | 78 | 1.52 | $2,044,740 | $522,371 |
| 2017 | 1,071 | 4,711 | 78 | 1.56 | $1,802,780 | $450,825 |
| 2016 | 1,002 | 5,486 | 78 | 1.72 | $1,822,918 | $511,014 |
| 2015 | 875 | 6,135 | 78 | 1.60 | $1,061,371 | $426,466 |
| 2014 | 808 | 7,076 | 78 | 1.43 | $1,253,143 | $496,589 |
| 2013 | 746 | 5,199 | 78 | 1.49 | $949,657 | $370,173 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 37 services
| Return visit (30+ min) | 538 | $89,665 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 223 | $47,521 | $196 |
| Ultrasound of both sides of head and neck blood flow | 122 | $24,617 | $202 |
| Long return visit (40+ min) | 95 | $20,554 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $18,083 | $109 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 35 | $16,976 | $485 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $12,793 | $156 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 40 | $12,154 | $77 |
| New patient visit (45+ min) | 60 | $8,396 | $140 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 36 | $8,253 | $229 |
| Short return visit (20+ min) | 108 | $7,479 | $66 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,046 | $470 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 104 | $6,746 | $62 |
| Ultrasound of leg arteries or artery grafts | 20 | $5,594 | $266 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 80 | $5,456 | $68 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 67 | $4,982 | $38 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 81 | $4,650 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 68 | $4,483 | $24 |
| Injection, regadenoson, 0.1 mg | 27 | $4,478 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 284 | $4,068 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | $3,534 | $196 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 25 | $3,050 | $22 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 107 | $2,919 | $23 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 16 | $2,759 | $162 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 39 | $2,642 | $22 |
| Programming of dual lead pacemaker system | 55 | $1,829 | $32 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 19 | $1,708 | $81 |
| Heart rhythm recording of continous external ekg over 8-15 days | 107 | $1,639 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 173 | $1,455 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 34 | $891 | $26 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 21 | $880 | $42 |
| Ultrasound study of arm and leg arteries | 12 | $846 | $71 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $687 | $62 |
| Programming of dual lead implantable defibrillator system | 11 | $676 | $52 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $584 | $32 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 33 | $418 | $11 |
| Ultrasonic guidance for blood vessel access | 17 | $212 | $12 |
2022: 39 services
| Return visit (30+ min) | 529 | $96,425 | $113 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 267 | $59,215 | $201 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 95 | $47,669 | $248 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 93 | $45,200 | $481 |
| Long return visit (40+ min) | 159 | $36,413 | $165 |
| Ultrasound of both sides of head and neck blood flow | 141 | $28,579 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $18,578 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $15,975 | $176 |
| Short return visit (20+ min) | 170 | $13,487 | $72 |
| New patient visit (45+ min) | 64 | $9,389 | $147 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $8,813 | $464 |
| Injection, regadenoson, 0.1 mg | 42 | $8,186 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $7,450 | $248 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 110 | $7,283 | $64 |
| Transitional care management services for problem of high complexity | 25 | $7,031 | $270 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $6,484 | $62 |
| Ultrasound of leg arteries or artery grafts | 25 | $6,235 | $249 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 55 | $5,729 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 103 | $4,820 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 92 | $4,655 | $22 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,001 | $200 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 272 | $3,967 | $13 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 28 | $3,560 | $23 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 17 | $3,285 | $193 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 45 | $2,633 | $21 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 99 | $2,565 | $23 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 15 | $2,204 | $147 |
| Ultrasound study of arm and leg arteries | 26 | $1,872 | $72 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 19 | $1,826 | $83 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 235 | $1,730 | $7 |
| Heart rhythm recording of continous external ekg over 8-15 days | 98 | $1,627 | $15 |
| Programming of dual lead pacemaker system | 30 | $1,276 | $39 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $823 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 29 | $774 | $27 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $656 | $31 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 15 | $654 | $44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 47 | $557 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 17 | $384 | $23 |
| Ultrasonic guidance for blood vessel access | 19 | $233 | $12 |
2021: 41 services
| Return visit (30+ min) | 496 | $98,218 | $115 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 154 | $80,653 | $524 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 262 | $59,518 | $208 |
| Long return visit (40+ min) | 228 | $57,354 | $170 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 151 | $41,567 | $138 |
| Ultrasound of both sides of head and neck blood flow | 119 | $25,057 | $211 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 108 | $22,604 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 110 | $21,506 | $175 |
| Short return visit (20+ min) | 138 | $13,273 | $80 |
| Injection, regadenoson, 0.1 mg | 63 | $11,994 | None |
| New patient visit (45+ min) | 72 | $11,092 | $154 |
| Transitional care management services for problem of high complexity | 38 | $10,386 | $273 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 149 | $10,112 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 160 | $10,083 | $63 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $9,952 | $243 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 43 | $6,574 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 105 | $5,945 | $25 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $5,341 | $232 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 80 | $4,545 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 279 | $4,063 | $14 |
| Ultrasound of leg arteries or artery grafts | 14 | $3,934 | $281 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 20 | $3,763 | $179 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 28 | $3,295 | $23 |
| Transitional care management services for problem of at least moderate complexity | 17 | $3,190 | $188 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 27 | $2,989 | $23 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 98 | $2,588 | $25 |
| New patient visit (60+ min) | 11 | $2,348 | $213 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,920 | $91 |
| Heart rhythm recording of continous external ekg over 8-15 days | 98 | $1,716 | $16 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 28 | $1,578 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 184 | $1,526 | $8 |
| Programming of dual lead pacemaker system | 40 | $1,418 | $32 |
| Ultrasound study of arm and leg arteries | 16 | $1,234 | $77 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,187 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $1,122 | $27 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $1,085 | $68 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 18 | $777 | $43 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 32 | $764 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 41 | $503 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $285 | $20 |
| Ultrasonic guidance for blood vessel access | 20 | $265 | $13 |
2020: 35 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 139 | $79,276 | $518 |
| Return visit (30+ min) | 464 | $75,961 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 254 | $57,227 | $211 |
| Long return visit (40+ min) | 203 | $39,846 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $39,339 | $97 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 140 | $28,398 | $99 |
| Ultrasound of both sides of head and neck blood flow | 101 | $21,559 | $211 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $21,387 | $188 |
| New patient visit (45+ min) | 91 | $13,445 | $148 |
| Injection, regadenoson, 0.1 mg | 65 | $12,290 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 143 | $10,039 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 105 | $7,678 | $69 |
| Short return visit (20+ min) | 101 | $6,303 | $58 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 47 | $5,724 | $25 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 87 | $5,258 | $26 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 17 | $4,309 | $253 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $3,835 | $104 |
| Ultrasound of leg arteries or artery grafts | 14 | $3,732 | $267 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 221 | $3,625 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 62 | $3,569 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 108 | $3,246 | $27 |
| Transitional care management services for problem of high complexity | 13 | $3,158 | $243 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $3,050 | $218 |
| Telephone medical discussion with physician, 11-20 minutes | 41 | $2,913 | $69 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 31 | $2,851 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 108 | $2,849 | $24 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 13 | $2,498 | $192 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $2,411 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 27 | $2,128 | $33 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 15 | $1,122 | $75 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 116 | $957 | $8 |
| Programming of dual lead pacemaker system | 24 | $931 | $34 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $482 | $28 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 31 | $375 | $11 |
| Heart muscle strain imaging | 12 | $133 | $11 |
2019: 35 services
| Return visit (30+ min) | 494 | $78,823 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 136 | $66,492 | $475 |
| Long return visit (40+ min) | 266 | $62,943 | $135 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 230 | $52,398 | $205 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 126 | $45,627 | $95 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 154 | $29,950 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 128 | $27,641 | $184 |
| Ultrasound of both sides of head and neck blood flow | 97 | $20,029 | $206 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $12,393 | $459 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 156 | $10,208 | $63 |
| New patient visit (45+ min) | 66 | $9,840 | $149 |
| Injection, regadenoson, 0.1 mg | 44 | $8,061 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 112 | $8,033 | $68 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $6,165 | $220 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 23 | $5,679 | $237 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 84 | $4,753 | $26 |
| Short return visit (20+ min) | 56 | $3,976 | $58 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 66 | $3,444 | $26 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 34 | $3,048 | $85 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $2,969 | $23 |
| Ultrasound of leg arteries or artery grafts | 11 | $2,966 | $270 |
| External ekg recording for more than 48 hours up to 21 days | 91 | $2,791 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 150 | $2,592 | $16 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 90 | $2,482 | $24 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 16 | $2,447 | $153 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 36 | $2,151 | $13 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 26 | $2,056 | $38 |
| Programming of dual lead pacemaker system | 38 | $1,533 | $33 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 21 | $1,519 | $69 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 20 | $1,460 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 170 | $1,414 | $7 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 21 | $1,047 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $651 | $27 |
| Programming of dual lead implantable defibrillator system | 12 | $597 | $50 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 49 | $579 | $11 |
2018: 36 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 154 | $78,932 | $509 |
| Long return visit (40+ min) | 324 | $78,363 | $133 |
| Return visit (30+ min) | 461 | $68,409 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 147 | $52,614 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 194 | $43,688 | $206 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 155 | $29,424 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 126 | $26,560 | $182 |
| Ultrasound of both sides of head and neck blood flow | 117 | $24,134 | $206 |
| New patient visit (45+ min) | 77 | $11,472 | $149 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 158 | $9,842 | $61 |
| Injection, regadenoson, 0.1 mg | 52 | $9,186 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 125 | $8,998 | $65 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,577 | $470 |
| Short return visit (20+ min) | 96 | $5,275 | $50 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $5,270 | $211 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $5,148 | $234 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 78 | $4,885 | $26 |
| Ultrasound of leg arteries or artery grafts | 16 | $4,370 | $273 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 20 | $3,923 | $196 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 17 | $3,662 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 60 | $3,432 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 196 | $3,336 | $16 |
| External ekg recording for more than 48 hours up to 21 days | 83 | $2,636 | $28 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 18 | $2,483 | $46 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 83 | $2,305 | $25 |
| Programming of dual lead pacemaker system | 46 | $2,063 | $31 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 18 | $1,948 | $12 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 18 | $1,486 | $83 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 111 | $873 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $860 | $72 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $583 | $26 |
| Programming of dual lead implantable defibrillator system | 11 | $581 | $45 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 47 | $529 | $11 |
| Programming of single lead pacemaker system | 11 | $510 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $261 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $189 | $13 |
2017: 40 services
| Return visit (30+ min) | 446 | $89,383 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 115 | $57,446 | $500 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 206 | $50,165 | $224 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 156 | $44,733 | $93 |
| Ultrasound of both sides of head and neck blood flow | 123 | $24,227 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 117 | $23,568 | $181 |
| Short return visit (20+ min) | 263 | $21,224 | $60 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 114 | $18,080 | $95 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 33 | $8,818 | $267 |
| Ultrasound of leg arteries or artery grafts | 33 | $8,775 | $258 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $8,106 | $477 |
| New patient visit (45+ min) | 54 | $7,971 | $148 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 117 | $7,700 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 113 | $6,701 | $57 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 32 | $5,971 | $187 |
| Long return visit (40+ min) | 34 | $5,953 | $129 |
| Injection, regadenoson, 0.1 mg | 34 | $5,903 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 17 | $3,600 | $200 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 18 | $3,337 | $159 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 19 | $3,268 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 167 | $2,862 | $16 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 24 | $2,839 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 50 | $2,789 | $26 |
| Programming of dual lead pacemaker system | 36 | $2,609 | $33 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 22 | $2,066 | $83 |
| External ekg recording for more than 48 hours up to 21 days | 58 | $1,748 | $27 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 18 | $1,721 | $12 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 16 | $1,625 | $86 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 29 | $1,605 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 58 | $1,515 | $24 |
| Programming of dual lead implantable defibrillator system | 17 | $1,418 | $49 |
| New patient visit (30+ min) | 16 | $1,356 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 165 | $1,328 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 17 | $1,215 | $71 |
| Programming of single lead pacemaker system | 17 | $888 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $859 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 47 | $567 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $309 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $261 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $175 | $13 |
2016: 39 services
| Return visit (30+ min) | 463 | $97,364 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 146 | $76,231 | $502 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 167 | $66,665 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 230 | $54,799 | $224 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 138 | $28,139 | $177 |
| Ultrasound of both sides of head and neck blood flow | 94 | $18,494 | $195 |
| Short return visit (20+ min) | 199 | $17,183 | $64 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 144 | $16,315 | $95 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 128 | $13,704 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 146 | $10,273 | $65 |
| Long return visit (40+ min) | 61 | $10,127 | $132 |
| New patient visit (45+ min) | 56 | $8,253 | $147 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 36 | $7,908 | $220 |
| Injection, regadenoson, 0.1 mg | 41 | $7,271 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 118 | $7,229 | $57 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,980 | $436 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 56 | $4,735 | $80 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 15 | $4,113 | $274 |
| Ultrasound of leg arteries or artery grafts | 21 | $3,944 | $188 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 18 | $3,500 | $194 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 157 | $2,938 | $16 |
| Critical care, first 30-74 minutes | 12 | $2,935 | $196 |
| Programming of dual lead pacemaker system | 37 | $2,393 | $36 |
| Programming of dual lead implantable defibrillator system | 26 | $1,796 | $51 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 19 | $1,570 | $83 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $1,543 | $55 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 57 | $1,353 | $16 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 19 | $1,321 | $70 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 26 | $1,258 | $25 |
| Blood test, clotting time | 82 | $1,244 | $5 |
| New patient visit (30+ min) | 13 | $1,178 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 135 | $1,019 | $7 |
| External ekg recording for more than 48 hours up to 21 days | 31 | $900 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 31 | $770 | $23 |
| Hospital discharge day management, 30 minutes or less | 11 | $657 | $60 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 14 | $641 | $27 |
| Programming of single lead pacemaker system | 13 | $630 | $27 |
| Short return visit | 20 | $541 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $401 | $27 |
2015: 32 services
| Return visit (30+ min) | 486 | $117,044 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 155 | $50,666 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 97 | $50,072 | $496 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 211 | $48,455 | $217 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 123 | $23,828 | $177 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 97 | $16,014 | $131 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 123 | $7,614 | $18 |
| Short return visit (20+ min) | 93 | $7,544 | $60 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 30 | $6,775 | $226 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 101 | $6,709 | $64 |
| Blood test, clotting time | 130 | $6,579 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 102 | $6,414 | $56 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 66 | $6,386 | $84 |
| New patient visit (45+ min) | 43 | $6,008 | $140 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 87 | $6,005 | $17 |
| Injection, regadenoson, 0.1 mg | 34 | $5,643 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 18 | $5,142 | $271 |
| Ultrasound of both sides of head and neck blood flow | 25 | $4,935 | $197 |
| Short return visit | 98 | $4,105 | $40 |
| Programming of dual lead pacemaker system | 49 | $3,825 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 164 | $3,270 | $16 |
| Programming of dual lead implantable defibrillator system | 16 | $1,609 | $73 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $1,605 | $55 |
| Ultrasound of leg arteries at rest and after exercise | 11 | $1,567 | $142 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 152 | $1,284 | $7 |
| Initial hospital observation care per day, typically 30 minutes | 14 | $1,234 | $88 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $1,133 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 24 | $1,111 | $25 |
| Programming of single lead pacemaker system | 13 | $893 | $43 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $507 | $27 |
| Injection, aminophyllin, up to 250 mg | 34 | $155 | None |
| Infusion, normal saline solution, 250 cc | 35 | $11 | None |
2014: 35 services
| Return visit (30+ min) | 552 | $127,155 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 125 | $66,384 | $488 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 217 | $51,415 | $221 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $49,504 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 134 | $26,453 | $178 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 125 | $21,145 | $131 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 163 | $11,487 | $18 |
| New patient visit (45+ min) | 68 | $9,751 | $143 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 134 | $9,430 | $63 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 38 | $9,136 | $240 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 96 | $8,945 | $80 |
| Blood test, clotting time | 161 | $8,169 | $5 |
| Ultrasound of both sides of head and neck blood flow | 42 | $8,154 | $194 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 127 | $8,037 | $57 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 27 | $7,556 | $280 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 104 | $7,508 | $17 |
| Injection, regadenoson, 0.1 mg | 38 | $6,812 | None |
| Short return visit | 123 | $5,042 | $38 |
| Ultrasound of leg arteries or artery grafts | 18 | $4,473 | $235 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 235 | $4,352 | $15 |
| Long return visit (40+ min) | 29 | $3,785 | $118 |
| Programming of dual lead pacemaker system | 40 | $3,643 | $50 |
| Ultrasound of leg arteries at rest and after exercise | 18 | $2,671 | $141 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $1,953 | $50 |
| Programming of dual lead implantable defibrillator system | 18 | $1,918 | $71 |
| Short return visit (20+ min) | 27 | $1,644 | $55 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 19 | $1,350 | $71 |
| Programming of single lead pacemaker system | 19 | $1,350 | $40 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 22 | $1,247 | $23 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,113 | $65 |
| Hospital observation care on day of discharge | 13 | $848 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $716 | $27 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 14 | $351 | $23 |
| Injection, aminophyllin, up to 250 mg | 38 | $76 | None |
| Infusion, normal saline solution, 250 cc | 39 | $11 | None |
2013: 34 services
| Return visit (30+ min) | 431 | $98,520 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 171 | $55,324 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 73 | $39,162 | $509 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 158 | $30,406 | $182 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 148 | $27,531 | $172 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 73 | $10,514 | $130 |
| New patient visit (45+ min) | 63 | $8,530 | $135 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 132 | $7,906 | $55 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 115 | $7,360 | $18 |
| Blood test, clotting time | 161 | $5,549 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 81 | $5,481 | $66 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $5,141 | $224 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 67 | $4,772 | $17 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 55 | $4,744 | $82 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $3,652 | $304 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 150 | $3,406 | $17 |
| Ultrasound of both sides of head and neck blood flow | 17 | $3,188 | $188 |
| Short return visit | 74 | $3,126 | $41 |
| Programming of dual lead pacemaker system | 37 | $2,585 | $47 |
| Injection, regadenoson, 0.1 mg | 13 | $2,053 | None |
| Short return visit (20+ min) | 29 | $2,041 | $60 |
| Long return visit (40+ min) | 16 | $2,006 | $125 |
| Hospital observation care on day of discharge | 28 | $1,923 | $64 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 26 | $1,693 | $63 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $1,257 | $57 |
| Programming of dual lead implantable defibrillator system | 12 | $968 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $936 | $62 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 17 | $781 | $26 |
| Programming of single lead pacemaker system | 11 | $656 | $44 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $309 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $230 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 25 | $193 | $7 |
| Injection, aminophyllin, up to 250 mg | 13 | $9 | None |
| Infusion, normal saline solution, 250 cc | 14 | $3 | None |
Medicaid work
$1,459 in 2024
Medicaid paid $1,459 for 218 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Anticoagulant management for a patient taking warfarin, must include review and interpretation of a new home, office, or lab international normalized ratio (INR) test result, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s), when performed | 140 | $1,110 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 78 | $348 |
| 2024 | 218 | 2 | 30 | $1,459 |
| 2023 | 69 | 1 | 24 | $424 |
| 2022 | 87 | 1 | 20 | $391 |
| 2021 | 59 | 1 | 21 | $171 |
| 2020 | 39 | 1 | 18 | $199 |
| 2019 | 38 | 1 | 20 | $143 |
| 2018 | 26 | 1 | 12 | $191 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 69 | $424 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 87 | $391 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 59 | $171 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 39 | $199 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 38 | $143 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 26 | $191 |
Drugs they prescribed that Part D paid
$1,330,273
Pharmacies billed $1,330,273 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,742) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
3,844 generic and 898 brand-name prescriptions · $1,330,273 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 417 | $555,542 | $1,332 |
| Vyndamax | 11 | $242,484 | $22,044 |
| Repatha Sureclick | 127 | $129,061 | $1,016 |
| Jardiance | 118 | $119,023 | $1,009 |
| Xarelto | 65 | $102,183 | $1,572 |
See all 54 drugs
| Eliquis | 417 | $555,542 | $1,332 |
| Vyndamax | 11 | $242,484 | $22,044 |
| Repatha Sureclick | 127 | $129,061 | $1,016 |
| Jardiance | 118 | $119,023 | $1,009 |
| Xarelto | 65 | $102,183 | $1,572 |
| Praluent | 29 | $28,098 | $969 |
| Entresto | 21 | $26,906 | $1,281 |
| Brilinta | 36 | $23,474 | $652 |
| Rosuvastatin | 292 | $6,599 | $23 |
| Atorvastatin | 503 | $6,406 | $13 |
| Ezetimibe | 113 | $5,286 | $47 |
| Metoprolol | 323 | $5,095 | $16 |
| Diltiazem 24hr Er (Cd) | 131 | $3,868 | $30 |
| Chlorthalidone | 145 | $3,519 | $24 |
| Losartan | 270 | $3,326 | $12 |
| Potassium Chloride | 103 | $3,135 | $30 |
| Flecainide Acetate | 74 | $2,831 | $38 |
| Amlodipine Besylate | 250 | $2,827 | $11 |
| Olmesartan Medoxomil | 101 | $2,748 | $27 |
| Verapamil Sr | 12 | $2,523 | $210 |
| Clopidogrel | 123 | $1,890 | $15 |
| Amiodarone | 11 | $1,494 | $136 |
| Metoprolol | 136 | $1,443 | $11 |
| Valsartan | 23 | $1,403 | $61 |
| Clonidine | 18 | $1,372 | $76 |
| Prasugrel | 17 | $1,229 | $72 |
| Bumetanide | 32 | $1,210 | $38 |
| Isosorbide Mononitrate Er | 54 | $1,119 | $21 |
| Losartan-Hydrochlorothiazide | 69 | $1,114 | $16 |
| Verapamil Er | 30 | $1,082 | $36 |
| Carvedilol | 108 | $845 | $8 |
| Warfarin | 48 | $837 | $17 |
| Lisinopril | 100 | $818 | $8 |
| Benazepril | 24 | $787 | $33 |
| Nebivolol | 17 | $778 | $46 |
| Sotalol Af | 30 | $755 | $25 |
| Pravastatin | 48 | $743 | $15 |
| Triamterene-Hydrochlorothiazid | 38 | $738 | $19 |
| Sotalol | 31 | $737 | $24 |
| Diltiazem 24hr Er | 14 | $734 | $52 |
| Nifedipine Er | 15 | $732 | $49 |
| Furosemide | 106 | $643 | $6 |
| Nitroglycerin | 31 | $582 | $19 |
| Hydrochlorothiazide | 122 | $561 | $5 |
| Digoxin | 21 | $410 | $20 |
| Atenolol | 33 | $390 | $12 |
| Fludrocortisone Acetate | 11 | $325 | $30 |
| Spironolactone | 29 | $317 | $11 |
| Hydralazine | 18 | $302 | $17 |
| Simvastatin | 33 | $298 | $9 |
| Clonidine | 24 | $236 | $10 |
| Lisinopril-Hydrochlorothiazide | 11 | $194 | $18 |
| Torsemide | 14 | $174 | $12 |
| Ramipril | 17 | $76 | $4 |
Year by year
| 2024 | 4,742 | 579 | 0% (0) | 19% | $1,330,273 |
| 2023 | 4,876 | 581 | 0% (0) | 18% | $1,306,224 |
| 2022 | 4,609 | 568 | 0% (0) | 17% | $1,196,435 |
| 2021 | 4,550 | 535 | 0% (0) | 18% | $774,341 |
| 2020 | 4,573 | 493 | 0% (0) | 20% | $748,604 |
| 2019 | 4,446 | 451 | 0% (0) | 17% | $576,181 |
| 2018 | 4,114 | 423 | None | None | $478,884 |
| 2017 | 4,087 | 406 | None | None | $417,230 |
| 2016 | 4,548 | 411 | None | None | $334,314 |
| 2015 | 4,131 | 365 | None | 21% | $251,562 |
| 2014 | 3,226 | 335 | 0% (0) | 23% | $181,128 |
| 2013 | 2,286 | 223 | None | None | $118,393 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 49 drugs
| Eliquis | 430 | $505,518 | $1,176 |
| Xarelto | 92 | $127,268 | $1,383 |
| Repatha Sureclick | 100 | $115,997 | $1,160 |
| Jardiance | 73 | $68,094 | $933 |
| Praluent | 29 | $32,525 | $1,122 |
| Entresto | 22 | $22,539 | $1,024 |
| Brilinta | 37 | $20,791 | $562 |
| Rosuvastatin | 335 | $10,079 | $30 |
| Atorvastatin | 547 | $8,483 | $16 |
| Ezetimibe | 101 | $7,503 | $74 |
| Metoprolol | 372 | $7,498 | $20 |
| Potassium Chloride | 137 | $5,655 | $41 |
| Diltiazem 24hr Er (Cd) | 138 | $5,181 | $38 |
| Losartan | 294 | $4,951 | $17 |
| Olmesartan Medoxomil | 110 | $4,539 | $41 |
| Flecainide Acetate | 78 | $4,037 | $52 |
| Chlorthalidone | 125 | $3,783 | $30 |
| Clonidine | 11 | $3,575 | $325 |
| Amlodipine Besylate | 261 | $2,635 | $10 |
| Sotalol Af | 32 | $2,417 | $76 |
| Clopidogrel | 107 | $2,000 | $19 |
| Carvedilol | 109 | $1,745 | $16 |
| Valsartan | 22 | $1,600 | $73 |
| Nifedipine Er | 22 | $1,598 | $73 |
| Isosorbide Mononitrate Er | 46 | $1,540 | $33 |
| Prasugrel | 18 | $1,445 | $80 |
| Metoprolol | 135 | $1,423 | $11 |
| Sotalol | 34 | $1,362 | $40 |
| Warfarin | 50 | $1,323 | $26 |
| Bumetanide | 23 | $1,323 | $58 |
| Furosemide | 147 | $1,074 | $7 |
| Verapamil Er | 32 | $1,068 | $33 |
| Losartan-Hydrochlorothiazide | 49 | $1,063 | $22 |
| Pravastatin | 51 | $850 | $17 |
| Lisinopril | 101 | $829 | $8 |
| Digoxin | 30 | $795 | $26 |
| Eplerenone | 13 | $700 | $54 |
| Torsemide | 12 | $692 | $58 |
| Amiodarone | 20 | $537 | $27 |
| Pantoprazole | 20 | $524 | $26 |
| Nitroglycerin | 25 | $442 | $18 |
| Hydrochlorothiazide | 87 | $424 | $5 |
| Triamterene-Hydrochlorothiazid | 24 | $390 | $16 |
| Atenolol | 37 | $355 | $10 |
| Clonidine | 27 | $344 | $13 |
| Simvastatin | 29 | $311 | $11 |
| Ramipril | 14 | $306 | $22 |
| Hydralazine | 28 | $277 | $10 |
| Spironolactone | 23 | $202 | $9 |
2022: 45 drugs
| Eliquis | 426 | $482,312 | $1,132 |
| Repatha Sureclick | 73 | $88,564 | $1,213 |
| Xarelto | 74 | $86,794 | $1,173 |
| Praluent | 35 | $31,839 | $910 |
| Brilinta | 28 | $23,373 | $835 |
| Entresto | 19 | $19,341 | $1,018 |
| Jardiance | 21 | $15,811 | $753 |
| Rosuvastatin | 328 | $15,152 | $46 |
| Ezetimibe | 96 | $10,419 | $109 |
| Atorvastatin | 519 | $7,517 | $14 |
| Metoprolol | 291 | $6,357 | $22 |
| Flecainide Acetate | 84 | $6,029 | $72 |
| Potassium Chloride | 106 | $5,912 | $56 |
| Olmesartan Medoxomil | 97 | $5,310 | $55 |
| Chlorthalidone | 122 | $4,478 | $37 |
| Losartan | 291 | $4,418 | $15 |
| Diltiazem 24hr Er (Cd) | 131 | $4,371 | $33 |
| Valsartan | 25 | $4,155 | $166 |
| Clopidogrel | 123 | $2,564 | $21 |
| Amlodipine Besylate | 274 | $2,559 | $9 |
| Prasugrel | 24 | $2,457 | $102 |
| Bumetanide | 24 | $2,038 | $85 |
| Losartan-Hydrochlorothiazide | 55 | $1,856 | $34 |
| Metoprolol | 144 | $1,677 | $12 |
| Carvedilol | 92 | $1,585 | $17 |
| Isosorbide Mononitrate Er | 39 | $1,412 | $36 |
| Sotalol | 35 | $1,211 | $35 |
| Verapamil Er | 31 | $1,152 | $37 |
| Lisinopril | 106 | $1,079 | $10 |
| Nifedipine Er | 16 | $1,003 | $63 |
| Furosemide | 138 | $980 | $7 |
| Pravastatin | 65 | $978 | $15 |
| Warfarin | 48 | $931 | $19 |
| Nitroglycerin | 35 | $808 | $23 |
| Sotalol Af | 29 | $789 | $27 |
| Amiodarone | 25 | $726 | $29 |
| Atenolol | 38 | $721 | $19 |
| Digoxin | 24 | $571 | $24 |
| Simvastatin | 30 | $474 | $16 |
| Hydralazine | 23 | $445 | $19 |
| Pantoprazole | 17 | $409 | $24 |
| Triamterene-Hydrochlorothiazid | 30 | $378 | $13 |
| Hydrochlorothiazide | 79 | $331 | $4 |
| Clonidine | 23 | $294 | $13 |
| Spironolactone | 29 | $226 | $8 |
2021: 46 drugs
| Eliquis | 423 | $432,439 | $1,022 |
| Repatha Sureclick | 73 | $60,000 | $822 |
| Xarelto | 53 | $59,070 | $1,115 |
| Brilinta | 38 | $31,976 | $841 |
| Entresto | 17 | $17,411 | $1,024 |
| Praluent | 24 | $14,042 | $585 |
| Rosuvastatin | 261 | $11,260 | $43 |
| Atorvastatin | 522 | $9,565 | $18 |
| Flecainide Acetate | 86 | $8,208 | $95 |
| Ezetimibe | 94 | $7,730 | $82 |
| Olmesartan Medoxomil | 78 | $6,331 | $81 |
| Potassium Chloride | 126 | $6,015 | $48 |
| Metoprolol | 273 | $5,582 | $20 |
| Diltiazem 24hr Er (Cd) | 132 | $5,453 | $41 |
| Chlorthalidone | 140 | $5,230 | $37 |
| Losartan | 303 | $4,561 | $15 |
| Bumetanide | 31 | $4,393 | $142 |
| Valsartan | 34 | $3,197 | $94 |
| Edarbi | 12 | $2,792 | $233 |
| Clopidogrel | 124 | $2,428 | $20 |
| Amlodipine Besylate | 239 | $2,341 | $10 |
| Verapamil Er | 43 | $2,176 | $51 |
| Carvedilol | 119 | $1,790 | $15 |
| Nifedipine Er | 14 | $1,736 | $124 |
| Losartan-Hydrochlorothiazide | 46 | $1,730 | $38 |
| Clonidine | 13 | $1,640 | $126 |
| Metoprolol | 132 | $1,566 | $12 |
| Amiodarone | 43 | $1,502 | $35 |
| Metolazone | 21 | $1,485 | $71 |
| Warfarin | 65 | $1,393 | $21 |
| Furosemide | 152 | $1,262 | $8 |
| Pravastatin | 64 | $1,030 | $16 |
| Lisinopril | 95 | $999 | $11 |
| Sotalol | 30 | $789 | $26 |
| Isosorbide Mononitrate Er | 33 | $731 | $22 |
| Atenolol | 33 | $697 | $21 |
| Pantoprazole | 31 | $672 | $22 |
| Digoxin | 20 | $637 | $32 |
| Hydrochlorothiazide | 95 | $531 | $6 |
| Triamterene-Hydrochlorothiazid | 27 | $476 | $18 |
| Clonidine | 31 | $313 | $10 |
| Simvastatin | 36 | $295 | $8 |
| Nitroglycerin | 21 | $261 | $12 |
| Benazepril | 12 | $108 | $9 |
| Lisinopril-Hydrochlorothiazide | 11 | $81 | $7 |
| Spironolactone | 15 | $79 | $5 |
2020: 50 drugs
| Eliquis | 497 | $430,180 | $866 |
| Xarelto | 41 | $53,791 | $1,312 |
| Repatha Sureclick | 40 | $24,176 | $604 |
| Brilinta | 30 | $23,516 | $784 |
| Praluent | 32 | $21,617 | $676 |
| Pradaxa | 11 | $15,441 | $1,404 |
| Rosuvastatin | 252 | $12,712 | $50 |
| Atorvastatin | 480 | $9,094 | $19 |
| Potassium Chloride | 182 | $8,207 | $45 |
| Flecainide Acetate | 75 | $7,967 | $106 |
| Diltiazem 24hr Er (Cd) | 126 | $7,665 | $61 |
| Metoprolol | 260 | $6,315 | $24 |
| Ezetimibe | 95 | $6,309 | $66 |
| Bumetanide | 39 | $6,192 | $159 |
| Losartan | 273 | $4,213 | $15 |
| Olmesartan Medoxomil | 55 | $4,207 | $76 |
| Chlorthalidone | 94 | $4,166 | $44 |
| Losartan-Hydrochlorothiazide | 41 | $4,047 | $99 |
| Clopidogrel | 141 | $3,040 | $22 |
| Edarbi | 13 | $2,870 | $221 |
| Enoxaparin | 14 | $2,597 | $185 |
| Valsartan | 25 | $2,365 | $95 |
| Verapamil Er | 38 | $2,323 | $61 |
| Warfarin | 87 | $2,014 | $23 |
| Amlodipine Besylate | 222 | $1,949 | $9 |
| Carvedilol | 132 | $1,614 | $12 |
| Metoprolol | 136 | $1,568 | $12 |
| Lisinopril | 116 | $1,353 | $12 |
| Isosorbide Mononitrate Er | 29 | $1,325 | $46 |
| Furosemide | 177 | $1,322 | $7 |
| Pravastatin | 58 | $1,208 | $21 |
| Diltiazem 24hr Er | 14 | $940 | $67 |
| Dilt-Xr | 12 | $917 | $76 |
| Nifedipine Er | 12 | $895 | $75 |
| Sotalol | 30 | $879 | $29 |
| Amiodarone | 26 | $870 | $33 |
| Digoxin | 26 | $850 | $33 |
| Pantoprazole | 36 | $837 | $23 |
| Cartia Xt | 22 | $795 | $36 |
| Sotalol Af | 12 | $760 | $63 |
| Atenolol | 34 | $736 | $22 |
| Triamterene-Hydrochlorothiazid | 30 | $633 | $21 |
| Hydrochlorothiazide | 104 | $596 | $6 |
| Clonidine | 38 | $548 | $14 |
| Nitroglycerin | 41 | $528 | $13 |
| Ramipril | 12 | $434 | $36 |
| Simvastatin | 41 | $322 | $8 |
| Spironolactone | 16 | $184 | $12 |
| Benazepril | 12 | $138 | $12 |
| Lisinopril-Hydrochlorothiazide | 12 | $98 | $8 |
2019: 52 drugs
| Eliquis | 405 | $311,271 | $769 |
| Xarelto | 35 | $45,084 | $1,288 |
| Praluent | 21 | $18,337 | $873 |
| Brilinta | 28 | $17,468 | $624 |
| Rosuvastatin | 222 | $13,189 | $59 |
| Diltiazem 24hr Er (Cd) | 132 | $12,317 | $93 |
| Metoprolol | 273 | $9,337 | $34 |
| Atorvastatin | 466 | $9,245 | $20 |
| Potassium Chloride | 161 | $7,983 | $50 |
| Flecainide Acetate | 67 | $7,747 | $116 |
| Ezetimibe | 97 | $6,377 | $66 |
| Bumetanide | 40 | $5,202 | $130 |
| Repatha Sureclick | 11 | $4,864 | $442 |
| Clopidogrel | 183 | $3,559 | $19 |
| Losartan | 243 | $3,438 | $14 |
| Amlodipine Besylate | 234 | $2,852 | $12 |
| Chlorthalidone | 56 | $2,834 | $51 |
| Olmesartan Medoxomil | 14 | $2,205 | $157 |
| Warfarin | 94 | $2,056 | $22 |
| Verapamil Sr | 20 | $2,020 | $101 |
| Isosorbide Mononitrate Er | 42 | $1,772 | $42 |
| Carvedilol | 127 | $1,640 | $13 |
| Isosorbide Dinitrate | 14 | $1,621 | $116 |
| Metoprolol | 143 | $1,620 | $11 |
| Prasugrel | 15 | $1,565 | $104 |
| Lisinopril | 148 | $1,540 | $10 |
| Dilt-Xr | 16 | $1,507 | $94 |
| Cartia Xt | 44 | $1,316 | $30 |
| Furosemide | 141 | $1,291 | $9 |
| Digoxin | 27 | $1,240 | $46 |
| Pravastatin | 36 | $1,175 | $33 |
| Nitroglycerin | 56 | $1,174 | $21 |
| Hydrochlorothiazide | 144 | $1,152 | $8 |
| Sotalol | 32 | $1,063 | $33 |
| Nifedipine Er | 12 | $995 | $83 |
| Diltiazem 24hr Er | 16 | $951 | $59 |
| Losartan-Hydrochlorothiazide | 46 | $907 | $20 |
| Valsartan | 19 | $884 | $47 |
| Atenolol | 43 | $775 | $18 |
| Pantoprazole | 30 | $754 | $25 |
| Sotalol Af | 13 | $632 | $49 |
| Amiodarone | 25 | $590 | $24 |
| Simvastatin | 57 | $566 | $10 |
| Triamterene-Hydrochlorothiazid | 24 | $499 | $21 |
| Klor-Con 10 | 11 | $462 | $42 |
| Verapamil Er | 13 | $419 | $32 |
| Digox | 11 | $352 | $32 |
| Diltiazem | 13 | $327 | $25 |
| Clonidine | 25 | $305 | $12 |
| Spironolactone | 29 | $290 | $10 |
| Benazepril | 15 | $186 | $12 |
| Lisinopril-Hydrochlorothiazide | 19 | $123 | $6 |
2018: 56 drugs
| Eliquis | 321 | $235,888 | $735 |
| Xarelto | 44 | $32,004 | $727 |
| Praluent | 13 | $15,391 | $1,184 |
| Ezetimibe | 86 | $11,887 | $138 |
| Diltiazem 24hr Er (Cd) | 81 | $11,502 | $142 |
| Metoprolol | 304 | $11,447 | $38 |
| Brilinta | 15 | $11,173 | $745 |
| Atorvastatin | 483 | $10,020 | $21 |
| Rosuvastatin | 192 | $9,941 | $52 |
| Potassium Chloride | 134 | $6,829 | $51 |
| Niacin Er | 13 | $5,684 | $437 |
| Flecainide Acetate | 59 | $5,463 | $93 |
| Bystolic | 18 | $5,414 | $301 |
| Prasugrel | 16 | $4,347 | $272 |
| Bumetanide | 31 | $3,844 | $124 |
| Warfarin | 137 | $3,597 | $26 |
| Clopidogrel | 136 | $2,806 | $21 |
| Coumadin | 11 | $2,539 | $231 |
| Losartan | 210 | $2,175 | $10 |
| Amlodipine Besylate | 204 | $2,120 | $10 |
| Enoxaparin | 12 | $2,025 | $169 |
| Chlorthalidone | 39 | $1,818 | $47 |
| Digoxin | 26 | $1,816 | $70 |
| Cartia Xt | 55 | $1,779 | $32 |
| Valsartan | 38 | $1,505 | $40 |
| Carvedilol | 114 | $1,464 | $13 |
| Nifedipine Er | 11 | $1,438 | $131 |
| Olmesartan Medoxomil | 13 | $1,416 | $109 |
| Isosorbide Dinitrate | 14 | $1,403 | $100 |
| Isosorbide Mononitrate Er | 22 | $1,360 | $62 |
| Lisinopril | 123 | $1,350 | $11 |
| Sotalol Af | 14 | $1,326 | $95 |
| Verapamil Sr | 15 | $1,290 | $86 |
| Metoprolol | 141 | $1,262 | $9 |
| Pravastatin | 33 | $985 | $30 |
| Furosemide | 128 | $978 | $8 |
| Dilt-Xr | 14 | $946 | $68 |
| Digox | 12 | $892 | $74 |
| Hydrochlorothiazide | 118 | $852 | $7 |
| Diltiazem 24hr Er | 16 | $802 | $50 |
| Nitroglycerin | 37 | $790 | $21 |
| Losartan-Hydrochlorothiazide | 48 | $783 | $16 |
| Verapamil Er | 14 | $746 | $53 |
| Sotalol | 25 | $732 | $29 |
| Atenolol | 39 | $596 | $15 |
| Amiodarone | 21 | $591 | $28 |
| Valsartan-Hydrochlorothiazide | 12 | $557 | $46 |
| Celecoxib | 13 | $554 | $43 |
| Triamterene-Hydrochlorothiazid | 25 | $543 | $22 |
| Simvastatin | 57 | $526 | $9 |
| Ramipril | 12 | $392 | $33 |
| Spironolactone | 39 | $318 | $8 |
| Klor-Con 10 | 14 | $293 | $21 |
| Lisinopril-Hydrochlorothiazide | 18 | $167 | $9 |
| Clonidine | 19 | $145 | $8 |
| Benazepril | 15 | $117 | $8 |
2017: 57 drugs
| Eliquis | 280 | $171,949 | $614 |
| Xarelto | 25 | $17,019 | $681 |
| Brilinta | 37 | $15,673 | $424 |
| Zetia | 32 | $14,787 | $462 |
| Atorvastatin | 525 | $10,727 | $20 |
| Ranexa | 20 | $10,393 | $520 |
| Metoprolol | 294 | $9,650 | $33 |
| Ezetimibe | 39 | $9,262 | $237 |
| Bystolic | 37 | $9,002 | $243 |
| Effient | 16 | $8,890 | $556 |
| Potassium Chloride | 172 | $7,041 | $41 |
| Diltiazem 24hr Cd | 21 | $6,488 | $309 |
| Rosuvastatin | 65 | $5,647 | $87 |
| Crestor | 12 | $5,435 | $453 |
| Diltiazem 24hr Er | 80 | $4,865 | $61 |
| Clonidine | 18 | $4,840 | $269 |
| Flecainide Acetate | 42 | $4,567 | $109 |
| Warfarin | 189 | $4,147 | $22 |
| Vytorin | 16 | $3,254 | $203 |
| Valsartan | 46 | $2,650 | $58 |
| Clopidogrel | 123 | $2,519 | $20 |
| Digox | 21 | $1,990 | $95 |
| Digoxin | 36 | $1,919 | $53 |
| Cartia Xt | 64 | $1,895 | $30 |
| Isosorbide Mononitrate Er | 39 | $1,868 | $48 |
| Bumetanide | 20 | $1,820 | $91 |
| Amlodipine Besylate | 168 | $1,815 | $11 |
| Sotalol Af | 17 | $1,697 | $100 |
| Carvedilol | 160 | $1,628 | $10 |
| Isosorbide Dinitrate | 11 | $1,381 | $126 |
| Enoxaparin | 13 | $1,337 | $103 |
| Metoprolol | 147 | $1,299 | $9 |
| Losartan | 112 | $1,263 | $11 |
| Lisinopril | 136 | $1,235 | $9 |
| Nifedipine Er | 15 | $1,232 | $82 |
| Pravastatin | 39 | $1,222 | $31 |
| Furosemide | 155 | $1,035 | $7 |
| Verapamil Sr | 20 | $881 | $44 |
| Dilt-Xr | 16 | $807 | $50 |
| Hydrochlorothiazide | 95 | $779 | $8 |
| Simvastatin | 72 | $758 | $11 |
| Amiodarone | 31 | $721 | $23 |
| Losartan-Hydrochlorothiazide | 49 | $657 | $13 |
| Sotalol | 24 | $652 | $27 |
| Triamterene-Hydrochlorothiazid | 30 | $635 | $21 |
| Valsartan-Hydrochlorothiazide | 18 | $597 | $33 |
| Nitroglycerin | 26 | $527 | $20 |
| Verapamil Er | 11 | $511 | $46 |
| Atenolol | 26 | $459 | $18 |
| Celecoxib | 14 | $457 | $33 |
| Klor-Con 10 | 15 | $353 | $24 |
| Ramipril | 13 | $346 | $27 |
| Diltiazem | 15 | $230 | $15 |
| Levothyroxine | 12 | $200 | $17 |
| Spironolactone | 19 | $173 | $9 |
| Benazepril | 14 | $173 | $12 |
| Clonidine | 24 | $157 | $7 |
2016: 63 drugs
| Eliquis | 224 | $108,075 | $482 |
| Crestor | 97 | $34,851 | $359 |
| Zetia | 61 | $26,297 | $431 |
| Xarelto | 32 | $13,894 | $434 |
| Diltiazem 24hr Er | 137 | $12,621 | $92 |
| Atorvastatin | 602 | $12,104 | $20 |
| Metoprolol | 239 | $7,881 | $33 |
| Brilinta | 15 | $7,760 | $517 |
| Potassium Chloride | 186 | $7,107 | $38 |
| Effient | 11 | $6,871 | $625 |
| Warfarin | 330 | $5,500 | $17 |
| Bystolic | 23 | $4,541 | $197 |
| Ranexa | 14 | $4,374 | $312 |
| Vytorin | 13 | $4,092 | $315 |
| Rosuvastatin | 24 | $3,355 | $140 |
| Valsartan | 51 | $2,439 | $48 |
| Clonidine | 15 | $2,329 | $155 |
| Clopidogrel | 127 | $2,052 | $16 |
| Amlodipine Besylate | 204 | $1,847 | $9 |
| Tekturna | 12 | $1,807 | $151 |
| Carvedilol | 160 | $1,774 | $11 |
| Isosorbide Mononitrate Er | 46 | $1,706 | $37 |
| Lisinopril | 198 | $1,611 | $8 |
| Coumadin | 11 | $1,560 | $142 |
| Digoxin | 44 | $1,506 | $34 |
| Flecainide Acetate | 35 | $1,487 | $42 |
| Metoprolol | 170 | $1,481 | $9 |
| Diltiazem 24hr Cd | 19 | $1,479 | $78 |
| Losartan | 139 | $1,409 | $10 |
| Cilostazol | 20 | $1,355 | $68 |
| Bumetanide | 28 | $1,252 | $45 |
| Furosemide | 194 | $1,194 | $6 |
| Pravastatin | 50 | $1,121 | $22 |
| Digox | 26 | $973 | $37 |
| Simvastatin | 81 | $946 | $12 |
| Cartia Xt | 26 | $923 | $35 |
| Sotalol | 45 | $868 | $19 |
| Hydrochlorothiazide | 120 | $836 | $7 |
| Ramipril | 14 | $646 | $46 |
| Doxazosin Mesylate | 11 | $613 | $56 |
| Enalapril Maleate | 14 | $599 | $43 |
| Valsartan-Hydrochlorothiazide | 23 | $504 | $22 |
| Verapamil Er | 22 | $496 | $23 |
| Atenolol | 21 | $489 | $23 |
| Amiodarone | 28 | $474 | $17 |
| Triamterene-Hydrochlorothiazid | 22 | $459 | $21 |
| Dilt-Xr | 12 | $424 | $35 |
| Nitrostat | 16 | $424 | $26 |
| Felodipine Er | 12 | $385 | $32 |
| Klor-Con 10 | 18 | $336 | $19 |
| Losartan-Hydrochlorothiazide | 35 | $322 | $9 |
| Clonidine | 21 | $309 | $15 |
| Benazepril | 23 | $296 | $13 |
| Diltiazem | 20 | $247 | $12 |
| Levothyroxine | 11 | $223 | $20 |
| Taztia Xt | 11 | $220 | $20 |
| Omeprazole | 18 | $220 | $12 |
| Digitek | 14 | $213 | $15 |
| Sotalol Af | 15 | $178 | $12 |
| Spironolactone | 19 | $140 | $7 |
| Hydralazine | 11 | $135 | $12 |
| Pantoprazole | 11 | $117 | $11 |
| Lovastatin | 22 | $87 | $4 |
2015: 57 drugs
| Eliquis | 177 | $70,158 | $396 |
| Crestor | 89 | $33,723 | $379 |
| Xarelto | 30 | $13,475 | $449 |
| Atorvastatin | 509 | $9,453 | $19 |
| Zetia | 30 | $8,940 | $298 |
| Metoprolol | 225 | $7,962 | $35 |
| Diltiazem 24hr Er | 60 | $6,555 | $109 |
| Potassium Chloride | 216 | $6,200 | $29 |
| Warfarin | 324 | $5,726 | $18 |
| Valsartan | 47 | $5,699 | $121 |
| Ranexa | 17 | $4,794 | $282 |
| Procrit | 12 | $4,262 | $355 |
| Diltiazem 24hr Cd | 59 | $3,033 | $51 |
| Chantix | 11 | $2,913 | $265 |
| Enoxaparin | 12 | $2,452 | $204 |
| Benicar Hct | 12 | $2,348 | $196 |
| Bystolic | 14 | $2,325 | $166 |
| Midodrine | 15 | $2,199 | $147 |
| Carvedilol | 205 | $1,650 | $8 |
| Isosorbide Mononitrate Er | 54 | $1,644 | $30 |
| Clonidine | 12 | $1,608 | $134 |
| Tekturna | 12 | $1,588 | $132 |
| Cilostazol | 45 | $1,556 | $35 |
| Bumetanide | 32 | $1,448 | $45 |
| Amlodipine Besylate | 196 | $1,418 | $7 |
| Digoxin | 34 | $1,304 | $38 |
| Lisinopril | 212 | $1,226 | $6 |
| Metoprolol | 154 | $1,180 | $8 |
| Clopidogrel | 99 | $1,131 | $11 |
| Pravastatin | 45 | $1,094 | $24 |
| Digox | 23 | $986 | $43 |
| Diltiazem Er | 24 | $978 | $41 |
| Furosemide | 211 | $974 | $5 |
| Losartan | 103 | $961 | $9 |
| Ramipril | 17 | $910 | $54 |
| Flecainide Acetate | 17 | $852 | $50 |
| Cartia Xt | 25 | $750 | $30 |
| Sotalol | 35 | $639 | $18 |
| Simvastatin | 65 | $635 | $10 |
| Hydrochlorothiazide | 99 | $583 | $6 |
| Amiodarone | 51 | $478 | $9 |
| Verapamil Er | 16 | $464 | $29 |
| Doxazosin Mesylate | 11 | $452 | $41 |
| Nitrostat | 24 | $427 | $18 |
| Sotalol Af | 15 | $349 | $23 |
| Atenolol | 26 | $331 | $13 |
| Diltiazem | 19 | $291 | $15 |
| Digitek | 11 | $269 | $24 |
| Triamterene-Hydrochlorothiazid | 18 | $229 | $13 |
| Spironolactone | 30 | $218 | $7 |
| Benazepril | 20 | $209 | $10 |
| Pantoprazole | 24 | $203 | $8 |
| Clonidine | 32 | $196 | $6 |
| Lovastatin | 25 | $129 | $5 |
| Hydralazine | 11 | $110 | $10 |
| Losartan-Hydrochlorothiazide | 18 | $107 | $6 |
| Omeprazole | 13 | $49 | $4 |
2014: 49 drugs
| Crestor | 80 | $23,630 | $295 |
| Eliquis | 68 | $23,267 | $342 |
| Xarelto | 41 | $15,590 | $380 |
| Zetia | 41 | $10,466 | $255 |
| Diovan | 23 | $9,543 | $415 |
| Atorvastatin | 371 | $8,163 | $22 |
| Catapres-Tts 3 | 11 | $6,290 | $572 |
| Metoprolol | 130 | $5,511 | $42 |
| Enoxaparin | 14 | $5,182 | $370 |
| Potassium Chloride | 115 | $4,099 | $36 |
| Ranexa | 24 | $4,096 | $171 |
| Warfarin | 291 | $4,029 | $14 |
| Diltiazem 24hr Er | 69 | $3,090 | $45 |
| Tekturna | 13 | $2,127 | $164 |
| Diltiazem 24hr Cd | 37 | $2,034 | $55 |
| Carvedilol | 166 | $1,573 | $9 |
| Metoprolol | 173 | $1,424 | $8 |
| Amlodipine Besylate | 177 | $1,331 | $8 |
| Cilostazol | 25 | $1,292 | $52 |
| Clopidogrel | 97 | $1,230 | $13 |
| Ramipril | 19 | $1,222 | $64 |
| Pravastatin | 53 | $1,186 | $22 |
| Lisinopril | 162 | $1,144 | $7 |
| Losartan | 89 | $1,055 | $12 |
| Sotalol | 57 | $1,019 | $18 |
| Simvastatin | 67 | $816 | $12 |
| Isosorbide Mononitrate Er | 23 | $787 | $34 |
| Digoxin | 17 | $755 | $44 |
| Furosemide | 169 | $747 | $4 |
| Flecainide Acetate | 21 | $694 | $33 |
| Metoprolol-Hydrochlorothiazide | 11 | $564 | $51 |
| Sotalol Af | 19 | $451 | $24 |
| Klor-Con 10 | 15 | $427 | $28 |
| Cartia Xt | 18 | $394 | $22 |
| Nitrostat | 24 | $391 | $16 |
| Bumetanide | 15 | $317 | $21 |
| Atenolol | 21 | $316 | $15 |
| Clonidine | 33 | $276 | $8 |
| Hydralazine | 18 | $272 | $15 |
| Hydrochlorothiazide | 48 | $255 | $5 |
| Levothyroxine | 17 | $221 | $13 |
| Benazepril | 12 | $193 | $16 |
| Pantoprazole | 12 | $189 | $16 |
| Amiodarone | 13 | $168 | $13 |
| Spironolactone | 11 | $101 | $9 |
| Diltiazem | 11 | $101 | $9 |
| Omeprazole | 16 | $99 | $6 |
| Losartan-Hydrochlorothiazide | 12 | $81 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $70 | $6 |
2013: 41 drugs
| Crestor | 59 | $15,489 | $263 |
| Diovan | 39 | $12,759 | $327 |
| Xarelto | 45 | $12,487 | $277 |
| Atorvastatin | 200 | $6,640 | $33 |
| Metoprolol | 95 | $4,794 | $50 |
| Zetia | 22 | $4,102 | $186 |
| Diltiazem 24hr Er | 63 | $3,563 | $57 |
| Potassium Chloride | 92 | $3,539 | $38 |
| Ranexa | 25 | $3,076 | $123 |
| Warfarin | 211 | $3,016 | $14 |
| Clopidogrel | 67 | $2,640 | $39 |
| Tekturna | 13 | $1,507 | $116 |
| Amlodipine Besylate | 116 | $1,293 | $11 |
| Metoprolol | 128 | $1,256 | $10 |
| Cilostazol | 16 | $971 | $61 |
| Simvastatin | 77 | $960 | $12 |
| Isosorbide Mononitrate Er | 30 | $900 | $30 |
| Furosemide | 157 | $837 | $5 |
| Lisinopril | 87 | $783 | $9 |
| Diltiazem Er | 18 | $775 | $43 |
| Losartan | 46 | $766 | $17 |
| Carvedilol | 66 | $693 | $11 |
| Sucralfate | 12 | $499 | $42 |
| Pravastatin | 30 | $486 | $16 |
| Sotalol | 34 | $368 | $11 |
| Levothyroxine | 26 | $361 | $14 |
| Clonidine | 26 | $335 | $13 |
| Flecainide Acetate | 11 | $313 | $28 |
| Amiodarone | 14 | $273 | $19 |
| Bumetanide | 20 | $269 | $13 |
| Fosinopril | 11 | $262 | $24 |
| Lovastatin | 11 | $256 | $23 |
| Verapamil Er | 17 | $250 | $15 |
| Nitrostat | 13 | $238 | $18 |
| Sotalol Af | 12 | $224 | $19 |
| Lisinopril-Hydrochlorothiazide | 15 | $186 | $12 |
| Digox | 22 | $172 | $8 |
| Hydrochlorothiazide | 35 | $165 | $5 |
| Carbamazepine | 12 | $155 | $13 |
| Famotidine | 11 | $116 | $11 |
| Fluoxetine | 11 | $87 | $8 |
Money from drug and device companies
$14 in 2020
| 2020 | 1 | 1 | None | $14 |
| 2019 | 2 | 18 | None | $159 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $14 | 1 payment
|
See the published payment
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2020-01-15 | Lifevest | $14 |
See earlier years (2019)
2019: $159
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $113 | 16 payments
|
| Sanofi-Aventis U.S. | Praluent | $46 | 2 payments
|
Professional record
- NPI
- 1013188051
- Licence
- CA A102865California A102865: Current · expires 2027-10-31
- Trained
- University of California, Irvine, California College of Medicine, 2001
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 2581 Samaritan Dr Ste 202, San Jose, CA, 95124
- NPI first listed
- 2008-03-18
- NPI last updated
- 2008-03-18
This is when the NPI record was last certified, not a medical board exam.